Insider Transactions in Q1 2023 at Avantor, Inc. (AVTR)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2023
|
Gerard Brophy EVP, Biopharma Production |
SELL
Open market or private sale
|
Direct |
3,914
-3.48%
|
$97,850
$25.0 P/Share
|
|
Feb 28
2023
|
Christophe Couturier EVP, AMEA |
SELL
Open market or private sale
|
Direct |
2,324
-2.26%
|
$55,776
$24.32 P/Share
|
|
Feb 27
2023
|
Gerard Brophy EVP, Biopharma Production |
SELL
Open market or private sale
|
Direct |
3,059
-2.64%
|
$76,475
$25.0 P/Share
|
|
Feb 25
2023
|
Steven W Eck SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
505
-2.27%
|
$12,120
$24.62 P/Share
|
|
Feb 25
2023
|
Gerard Brophy EVP, Biopharma Production |
SELL
Payment of exercise price or tax liability
|
Direct |
2,040
-1.73%
|
$48,960
$24.62 P/Share
|
|
Feb 25
2023
|
Michael Stubblefield President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,685
-0.6%
|
$184,440
$24.62 P/Share
|
|
Feb 25
2023
|
Sheri Lewis EVP, Global Ops & Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
1,340
-1.75%
|
$32,160
$24.62 P/Share
|
|
Feb 25
2023
|
Justin Miller EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
560
-0.53%
|
$13,440
$24.62 P/Share
|
|
Feb 25
2023
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Payment of exercise price or tax liability
|
Direct |
511
-0.49%
|
$12,264
$24.62 P/Share
|
|
Feb 25
2023
|
Meghan Henson EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
800
-1.95%
|
$19,200
$24.62 P/Share
|
|
Feb 25
2023
|
Christophe Couturier EVP, AMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
467
-0.45%
|
$11,208
$24.62 P/Share
|
|
Feb 25
2023
|
Frederic Vanderhaegen EVP, Americas and Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
299
-0.16%
|
$7,176
$24.62 P/Share
|
|
Feb 25
2023
|
Thomas A Szlosek EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,040
-1.91%
|
$48,960
$24.62 P/Share
|
|
Feb 24
2023
|
Steven W Eck SVP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,347
+19.38%
|
-
|
|
Feb 24
2023
|
Gerard Brophy EVP, Biopharma Production |
BUY
Grant, award, or other acquisition
|
Direct |
20,308
+14.71%
|
-
|
|
Feb 24
2023
|
Kitty Sahin EVP, Strategy&Corp Development |
BUY
Grant, award, or other acquisition
|
Direct |
12,185
+23.86%
|
-
|
|
Feb 24
2023
|
Michael Stubblefield President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
99,004
+7.14%
|
-
|
|
Feb 24
2023
|
Sheri Lewis EVP, Global Ops & Supply Chain |
BUY
Grant, award, or other acquisition
|
Direct |
12,185
+13.73%
|
-
|
|
Feb 24
2023
|
Justin Miller EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
9,138
+7.91%
|
-
|
|
Feb 24
2023
|
James Bramwell EVP Sales, Customer Excellence |
BUY
Grant, award, or other acquisition
|
Direct |
20,308
+16.23%
|
-
|
|
Feb 24
2023
|
Meghan Henson EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,185
+22.92%
|
-
|
|
Feb 24
2023
|
Christophe Couturier EVP, AMEA |
BUY
Grant, award, or other acquisition
|
Direct |
9,138
+8.11%
|
-
|
|
Feb 24
2023
|
Frederic Vanderhaegen EVP, Americas and Europe |
BUY
Grant, award, or other acquisition
|
Direct |
20,308
+9.74%
|
-
|
|
Feb 24
2023
|
Thomas A Szlosek EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
22,339
+17.29%
|
-
|
|
Feb 23
2023
|
Steven W Eck SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
421
-2.43%
|
$10,104
$24.59 P/Share
|
|
Feb 23
2023
|
Gerard Brophy EVP, Biopharma Production |
SELL
Payment of exercise price or tax liability
|
Direct |
1,893
-1.91%
|
$45,432
$24.59 P/Share
|
|
Feb 23
2023
|
Michael Stubblefield President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,422
-0.62%
|
$178,128
$24.59 P/Share
|
|
Feb 23
2023
|
Sheri Lewis EVP, Global Ops & Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
970
-1.48%
|
$23,280
$24.59 P/Share
|
|
Feb 23
2023
|
Justin Miller EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
468
-0.48%
|
$11,232
$24.59 P/Share
|
|
Feb 23
2023
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Payment of exercise price or tax liability
|
Direct |
569
-0.67%
|
$13,656
$24.59 P/Share
|
|
Feb 23
2023
|
Meghan Henson EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
816
-2.76%
|
$19,584
$24.59 P/Share
|
|
Feb 23
2023
|
Christophe Couturier EVP, AMEA |
SELL
Open market or private sale
|
Direct |
3,078
-3.16%
|
$73,872
$24.24 P/Share
|
|
Feb 23
2023
|
Christophe Couturier EVP, AMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
416
-0.43%
|
$9,984
$24.59 P/Share
|
|
Feb 23
2023
|
Frederic Vanderhaegen EVP, Americas and Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
213
-0.13%
|
$5,112
$24.59 P/Share
|
|
Feb 23
2023
|
Thomas A Szlosek EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,082
-2.29%
|
$49,968
$24.59 P/Share
|
|
Feb 22
2023
|
Christophe Couturier EVP, AMEA |
SELL
Open market or private sale
|
Direct |
19,160
-16.47%
|
$459,840
$24.12 P/Share
|
|
Feb 20
2023
|
Justin Miller EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,167
-1.18%
|
$28,008
$24.54 P/Share
|
|
Feb 20
2023
|
Steven W Eck SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
435
-2.45%
|
$10,440
$24.54 P/Share
|
|
Feb 20
2023
|
Thomas A Szlosek EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,253
-4.47%
|
$102,072
$24.54 P/Share
|
|
Feb 20
2023
|
Michael Stubblefield President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,026
-1.24%
|
$360,624
$24.54 P/Share
|
|
Feb 20
2023
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Payment of exercise price or tax liability
|
Direct |
1,066
-1.24%
|
$25,584
$24.54 P/Share
|
|
Feb 20
2023
|
Gerard Brophy EVP, Biopharma Production |
SELL
Payment of exercise price or tax liability
|
Direct |
3,072
-3.0%
|
$73,728
$24.54 P/Share
|
|
Feb 20
2023
|
Frederic Vanderhaegen EVP, Americas and Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
398
-0.24%
|
$9,552
$24.54 P/Share
|
|
Feb 20
2023
|
Christophe Couturier EVP, AMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
1,167
-0.99%
|
$28,008
$24.54 P/Share
|
|
Feb 20
2023
|
Michael Wondrasch EVP & CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,356
-1.39%
|
$32,544
$24.54 P/Share
|
|
Feb 02
2023
|
Gerard Brophy EVP, Biopharma Production |
SELL
Open market or private sale
|
Direct |
11,339
-9.97%
|
$283,475
$25.06 P/Share
|
|
Jan 31
2023
|
Frederic Vanderhaegen EVP, Americas and Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
2,515
-1.47%
|
$57,845
$23.9 P/Share
|
|
Jan 31
2023
|
Frederic Vanderhaegen EVP, Americas and Europe |
BUY
Grant, award, or other acquisition
|
Direct |
44,669
+20.71%
|
-
|
|
Jan 31
2023
|
Thomas A Szlosek EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
24,187
-16.26%
|
$556,301
$23.9 P/Share
|
|
Jan 31
2023
|
Thomas A Szlosek EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
53,636
+26.5%
|
-
|